Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 5,280 Shares of Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 5,280 shares of Phibro Animal Health stock in a transaction on Monday, November 17th. The shares were sold at an average price of $44.56, for a total transaction of $235,276.80. Following the completion of the transaction, the chief executive officer directly owned 54,960 shares of the company’s stock, valued at $2,449,017.60. The trade was a 8.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Jack Bendheim also recently made the following trade(s):

• On Thursday, November 13th, Jack Bendheim sold 8,801 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.47, for a total transaction of $391,380.47.
• On Wednesday, November 12th, Jack Bendheim sold 21,536 shares of Phibro Animal Health stock. The shares were sold at an average price of $45.23, for a total value of $974,073.28.
• On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.29, for a total value of $1,734,742.87.
• On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $42.86, for a total value of $150,867.20.
• On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $43.10, for a total value of $151,712.00.
• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.07, for a total transaction of $144,566.40.
• On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.56, for a total transaction of $146,291.20.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.18, for a total value of $141,433.60.
• On Wednesday, October 22nd, Jack Bendheim sold 11,859 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.27, for a total value of $477,561.93.
• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.38, for a total value of $649,108.50.

Phibro Animal Health Stock Performance

Shares of NASDAQ:PAHC opened at $43.38 on Wednesday. The company has a debt-to-equity ratio of 2.46, a current ratio of 2.76 and a quick ratio of 1.25. Phibro Animal Health Corporation has a 1 year low of $16.16 and a 1 year high of $46.42. The firm has a market capitalization of $1.76 billion, a PE ratio of 36.76, a P/E/G ratio of 1.24 and a beta of 0.81. The business’s 50 day moving average price is $40.58 and its 200-day moving average price is $32.34.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 EPS for the quarter, beating the consensus estimate of $0.58 by $0.15. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%.The firm had revenue of $363.89 million during the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. As a group, equities research analysts expect that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 17th. Investors of record on Wednesday, November 26th will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, November 26th. This represents a $0.48 dividend on an annualized basis and a yield of 1.1%. Phibro Animal Health’s payout ratio is presently 28.92%.

Institutional Investors Weigh In On Phibro Animal Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. National Bank of Canada FI purchased a new position in shares of Phibro Animal Health during the 1st quarter worth $30,000. Financial Management Professionals Inc. purchased a new position in Phibro Animal Health during the second quarter worth about $32,000. Hughes Financial Services LLC acquired a new stake in shares of Phibro Animal Health during the third quarter valued at about $40,000. iSAM Funds UK Ltd acquired a new position in shares of Phibro Animal Health in the 3rd quarter worth approximately $61,000. Finally, EverSource Wealth Advisors LLC boosted its position in shares of Phibro Animal Health by 7,671.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock worth $69,000 after purchasing an additional 2,685 shares during the period. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Analysts Set New Price Targets

PAHC has been the subject of a number of recent research reports. Morgan Stanley set a $34.00 price objective on shares of Phibro Animal Health in a report on Thursday, August 28th. Zacks Research downgraded Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. JPMorgan Chase & Co. upped their target price on Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a report on Friday, November 7th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Phibro Animal Health in a report on Monday. Finally, Bank of America upped their price objective on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a report on Friday, August 29th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $31.40.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.